These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32944474)

  • 21. Myasthenia Gravis and Crisis: Evaluation and Management in the Emergency Department.
    Roper J; Fleming ME; Long B; Koyfman A
    J Emerg Med; 2017 Dec; 53(6):843-853. PubMed ID: 28916122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress of myasthenia gravis: discovery of Lrp4 antibodies].
    Motomura M; Higuchi O
    Rinsho Shinkeigaku; 2012; 52(11):1303-5. PubMed ID: 23196599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-MuSK myasthenia gravis with prolonged remission.
    Bouwyn JP; Magnier P; Bédat-Millet AL; Ahtoy P; Maltête D; Lefaucheur R
    Neuromuscul Disord; 2016 Jul; 26(7):453-4. PubMed ID: 27161384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenia Gravis: A Rare Neurologic Complication of Immune Checkpoint Inhibitor Therapy.
    Shames Y; Errante M; Keteku NP
    J Adv Pract Oncol; 2022 Mar; 13(2):151-157. PubMed ID: 35369395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically Worsening Myasthenia-Related Respiratory Distress Notwithstanding Normal Markers of Respiratory Function.
    Ashraf H; Vayzband V
    Cureus; 2021 May; 13(5):e15250. PubMed ID: 34188989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Myasthenia gravis: current status of antibody diagnostics and aspects on refractory myasthenia gravis].
    Wenninger S; Schoser B
    Fortschr Neurol Psychiatr; 2018 Sep; 86(9):551-558. PubMed ID: 30248688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myasthenia gravis].
    Schodrowski J; Seipelt M; Adibi-Sedeh I; Eienbröker C; Tackenberg B
    Internist (Berl); 2016 Apr; 57(4):349-61. PubMed ID: 27000188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-agrin autoantibodies in myasthenia gravis.
    Gasperi C; Melms A; Schoser B; Zhang Y; Meltoranta J; Risson V; Schaeffer L; Schalke B; Kröger S
    Neurology; 2014 Jun; 82(22):1976-83. PubMed ID: 24793185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
    Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
    Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sero-Positive Isolated Ocular Myasthenia Gravis.
    Khan TA; Sadiq MZ; Khan AA; Zahid MA; Zameer S
    Cureus; 2024 Aug; 16(8):e66885. PubMed ID: 39280472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
    Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis: subgroup classification and therapeutic strategies.
    Gilhus NE; Verschuuren JJ
    Lancet Neurol; 2015 Oct; 14(10):1023-36. PubMed ID: 26376969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
    Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
    Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Complicated Case of Postpartum Myasthenic Crisis.
    Quigley R; Koenig ZA; Schick S; Miller E
    Cureus; 2021 Dec; 13(12):e20247. PubMed ID: 35018255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myasthenia, from the internist's point of view].
    Eymard B
    Rev Med Interne; 2014 Jul; 35(7):421-9. PubMed ID: 24112993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis.
    Mori S; Shigemoto K
    Autoimmun Rev; 2013 Jul; 12(9):912-7. PubMed ID: 23537506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pearls: myasthenia.
    Benatar M
    Semin Neurol; 2010 Feb; 30(1):35-7. PubMed ID: 20127579
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.